Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 4
1963 1
1964 1
1974 2
1975 16
1976 21
1977 45
1978 23
1979 25
1980 29
1981 26
1982 31
1983 39
1984 42
1985 58
1986 64
1987 97
1988 90
1989 80
1990 105
1991 73
1992 69
1993 82
1994 85
1995 96
1996 103
1997 98
1998 143
1999 237
2000 294
2001 340
2002 449
2003 564
2004 671
2005 736
2006 720
2007 724
2008 744
2009 842
2010 920
2011 1109
2012 1143
2013 1225
2014 1379
2015 1264
2016 1112
2017 911
2018 750
2019 568
2020 652
2021 506
2022 346
2023 287
2024 108

Text availability

Article attribute

Article type

Publication date

Search Results

18,275 results

Results by year

Filters applied: . Clear all
Page 1
Ribavirin pharmacokinetics.
Connor J. Connor J. Pediatr Infect Dis J. 1990 Sep;9(9 Suppl):S91-2. doi: 10.1097/00006454-199009001-00009. Pediatr Infect Dis J. 1990. PMID: 2235214 Review. No abstract available.
Ribavirin: Past, present and future.
Loustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P. Loustaud-Ratti V, et al. World J Hepatol. 2016 Jan 18;8(2):123-30. doi: 10.4254/wjh.v8.i2.123. World J Hepatol. 2016. PMID: 26807208 Free PMC article. Review.
All options currently available for the last difficult-to-treat cirrhotic G3 patients contain ribavirin. Reducing treatment duration to 12 wk in G1 or G4 cirrhotic compensated patients is feasible thanks to ribavirin. Retreating patients with acquired anti NS5A resi …
All options currently available for the last difficult-to-treat cirrhotic G3 patients contain ribavirin. Reducing treatment duration …
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.
Feld JJ, Jacobson IM, Sulkowski MS, Poordad F, Tatsch F, Pawlotsky JM. Feld JJ, et al. Liver Int. 2017 Jan;37(1):5-18. doi: 10.1111/liv.13212. Epub 2016 Sep 29. Liver Int. 2017. PMID: 27473533 Free PMC article. Review.
However, because of treatment-limiting side effects and its additive toxicity with interferon, the search for interferon- and ribavirin-free regimens has been underway. The recent approvals of all-oral direct acting antivirals (DAAs) have revolutionized the HCV therapeutic …
However, because of treatment-limiting side effects and its additive toxicity with interferon, the search for interferon- and ribavirin …
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies(1).
Cheng HY, French CE, Salam AP, Dawson S, McAleenan A, McGuinness LA, Savović J, Horby PW, Sterne JAC. Cheng HY, et al. Emerg Infect Dis. 2022 Aug;28(8):1559-1568. doi: 10.3201/eid2808.211787. Emerg Infect Dis. 2022. PMID: 35876478 Free PMC article. Review.
Ribavirin has been used widely to treat Lassa fever in West Africa since the 1980s. ...We identified 13 studies of the comparative effectiveness of ribavirin versus no ribavirin treatment on mortality outcomes, including unpublished data from a study in Sierr …
Ribavirin has been used widely to treat Lassa fever in West Africa since the 1980s. ...We identified 13 studies of the comparative ef …
Ribavirin's antiviral mechanism of action: lethal mutagenesis?
Crotty S, Cameron C, Andino R. Crotty S, et al. J Mol Med (Berl). 2002 Feb;80(2):86-95. doi: 10.1007/s00109-001-0308-0. Epub 2001 Dec 4. J Mol Med (Berl). 2002. PMID: 11907645 Review.
Here we recount the history of ribavirin and review recent reports regarding ribavirin's mechanism of action, including our studies demonstrating that ribavirin is an RNA virus mutagen and ribavirin's primary antiviral mechanism of action against a mod …
Here we recount the history of ribavirin and review recent reports regarding ribavirin's mechanism of action, including our st …
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
Borden KL, Culjkovic-Kraljacic B. Borden KL, et al. Leuk Lymphoma. 2010 Oct;51(10):1805-15. doi: 10.3109/10428194.2010.496506. Leuk Lymphoma. 2010. PMID: 20629523 Free PMC article. Review.
Ribavirin was discovered nearly 40 years ago as a broad-spectrum antiviral drug. ...Here we review the anticancer activities of ribavirin and discuss the possible utility of incorporating ribavirin into diverse cancer therapeutic regimens....
Ribavirin was discovered nearly 40 years ago as a broad-spectrum antiviral drug. ...Here we review the anticancer activities of ri …
Ribavirin for chronic hepatitis C: and the mystery goes on.
Brillanti S, Mazzella G, Roda E. Brillanti S, et al. Dig Liver Dis. 2011 Jun;43(6):425-30. doi: 10.1016/j.dld.2010.10.007. Epub 2010 Nov 18. Dig Liver Dis. 2011. PMID: 21093391 Review.
Twenty years ago, ribavirin was first used in the treatment for chronic hepatitis C. ...In the present review, the authors recall the milestones in the history of ribavirin and try to shed light on the more relevant features of ribavirin action and utilizatio …
Twenty years ago, ribavirin was first used in the treatment for chronic hepatitis C. ...In the present review, the authors recall the …
What future for ribavirin?
Shiffman ML. Shiffman ML. Liver Int. 2009 Jan;29 Suppl 1:68-73. doi: 10.1111/j.1478-3231.2008.01936.x. Liver Int. 2009. PMID: 19207968 Review.
The optimal therapy for patients with the chronic hepatitis C virus (HCV) is a combination of peginterferon and ribavirin. Treating HCV without ribavirin or prematurely discontinuing, frequently missing doses of ribavirin is associated with a significant decl …
The optimal therapy for patients with the chronic hepatitis C virus (HCV) is a combination of peginterferon and ribavirin. Treating H …
Ribavirin monitoring in chronic hepatitis C therapy: anaemia versus efficacy.
Brochot E, Castelain S, Duverlie G, Capron D, Nguyen-Khac E, François C. Brochot E, et al. Antivir Ther. 2010;15(5):687-95. doi: 10.3851/IMP1609. Antivir Ther. 2010. PMID: 20710050 Review.
The standard treatment of HCV infection with pegylated interferon-alpha2a or -alpha2b and ribavirin is effective in <50% of HCV genotype-1-infected patients. To improve this figure, it might be desirable to obtain optimal plasma concentrations of the drug by increasing …
The standard treatment of HCV infection with pegylated interferon-alpha2a or -alpha2b and ribavirin is effective in <50% of HCV ge …
Ribavirin: current role in the optimal clinical management of chronic hepatitis C.
Reddy KR, Nelson DR, Zeuzem S. Reddy KR, et al. J Hepatol. 2009 Feb;50(2):402-11. doi: 10.1016/j.jhep.2008.11.006. Epub 2008 Dec 3. J Hepatol. 2009. PMID: 19091439 Free article. Review.
Ribavirin in combination with peginterferon alfa shows strong clinical efficacy against chronic hepatitis C, and is now established as the standard of care. However, the precise role of ribavirin is still being defined, suggesting that optimal ribavirin dose …
Ribavirin in combination with peginterferon alfa shows strong clinical efficacy against chronic hepatitis C, and is now established a …
18,275 results
You have reached the last available page of results. Please see the User Guide for more information.